GI
Regulora delivers behavioral therapy based on gut-directed hypnotherapy through a smartphone app.
A new exploratory collaboration with Ironwood Pharmaceuticals comes just a couple weeks after the digital therapeutics startup ended a commercialization relationship with Novartis' Sandoz.
Blue Cross Blue Shield Venture Partners and Arboretum Ventures led the round.
The company looks to sell its chronic health offering to health plans and employers.